by Richard Daverman, PhD
February 7, 2014 -- Aslan Pharmaceuticals, a Singapore-headquartered biotech, has opened a new office in Taipei, Taiwan, from which it will run clinical trials. Previously, Aslan told ChinaBio® Today that Taiwan’s regulatory system is both quick to respond and open to innovative clinical trials. Aslan is an in-licensing company. It licenses molecules from western pharmas that have substantially completed their pre-clinical development, takes them through Phase II proof-of-concept trials, and then finds a partner for them. More details....
Help employers find you! Check out all the jobs and post your resume.
